Wesley Armstrong
@wes_armstrong_
MD PhD Student, UCLA-Caltech MSTP
ID: 1522673967269437440
06-05-2022 20:25:51
12 Tweet
20 Followers
46 Following
PSMA PET findings in an “EMBARK-like” cohort of HR nmHSPC Wesley Armstrong Jeremie Calais 📌 n=183 📌 med PSA: 2.4 (RP), 6.9 (dRT), 2.7 (RP+SRT), 2.8 (overall pop) 📌 PSMA PET+: 85.2%; 609 PSMA PET+ lesions; 3.9 mean number of lesions/case. 46% M1 dx! UroToday.com #ASCO23
PSMA PET findings in an “EMBARK-like” cohort of pts with high-risk #nmHSPC: a single center posthoc retrospective analysis. Presented by Wesley Armstrong UCLA-Caltech MSTP. #ASCO23 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/45CFtHM ASCO
PSMA PET guided salvage radiotherapy among patients with #ProstateCancer in the post-prostatectomy setting: a single center posthoc analysis. Presented by Jeremie Calais .. #ASCO23 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/3CbYt2w ASCO
Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: a surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter prospective phase 3 imaging trial. Presented by Djaïleb Loïc UCLA Theranostics > bit.ly/45OjzBF Zach Klaassen #ASCO23
Follow-up of the surgical cohort of the Pivotal Trial used for the FDA approval of 68Ga-PSMA-11 PET in European Urology: Pre-surgical PSMA-PET is a strong prognostic biomarker improving pre-operative BCR-FS risk assessment. sciencedirect.com/science/articl… x.com/UCLAJCCC/statu…
Great poster presentations and reception at the #2024PSMAConference! Congratulations to our awardees - Reinier Hernandez, @josef_zahner, and Wesley Armstrong !
Great work out in European Urology led by Wesley Armstrong on our . SRT randomized trial of PSMA vs SOC imaging before SRT, led by Jeremie Calais and Nick Nickols